Engineered Biosynthesis of Gilvocarcin Analogues with Altered Deoxyhexopyranose Moieties
- 15 January 2011
- journal article
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 77 (2) , 435-441
Abstract
A combinatorial biosynthetic approach was used to interrogate the donor substrate flexibility of GilGT, the glycosyltransferase involved in C -glycosylation during gilvocarcin biosynthesis. Complementation of gilvocarcin mutant Streptomyces lividans TK24 (cosG9B3-U − ), in which the biosynthesis of the natural sugar donor substrate was compromised, with various deoxysugar plasmids led to the generation of six gilvocarcin analogues with altered saccharide moieties. Characterization of the isolated gilvocarcin derivatives revealed five new compounds, including 4-β- C - d -olivosyl-gilvocarcin V ( d -olivosyl GV), 4-β- C - d -olivosyl-gilvocarcin M ( d -olivosyl GM), 4-β- C - d -olivosyl-gilvocarcin E ( d -olivosyl GE), 4-α- C - l -rhamnosyl-gilvocarcin M (polycarcin M), 4-α- C - l -rhamnosyl-gilvocarcin E (polycarcin E), and the recently characterized 4-α- C - l -rhamnosyl-gilvocarcin V (polycarcin V). Preliminary anticancer assays showed that d -olivosyl-gilvocarcin and polycarcin V exhibit antitumor activities comparable to that of their parent drug congener, gilvocarcin V, against human lung cancer (H460), murine lung cancer (LL/2), and breast cancer (MCF-7) cell lines. Our findings demonstrate GilGT to be a moderately flexible C -glycosyltransferase able to transfer both d - and l -hexopyranose moieties to the unique angucyclinone-derived benzo[ d ]naphtho[1,2 b ]pyran-6-one backbone of the gilvocarcins.Keywords
This publication has 43 references indexed in Scilit:
- Delineating the earliest steps of gilvocarcin biosynthesis: role of GilP and GilQ in starter unit specificityOrganic & Biomolecular Chemistry, 2010
- Cloning and Characterization of the Ravidomycin and Chrysomycin Biosynthetic Gene ClustersChemBioChem, 2010
- GilR, an Unusual Lactone‐Forming Enzyme Involved in Gilvocarcin BiosynthesisChemBioChem, 2009
- Inactivation of the Ketoreductase gilU Gene of the Gilvocarcin Biosynthetic Gene Cluster Yields New Analogues with Partly Improved Biological ActivityChemBioChem, 2009
- Natural‐Product Sugar Biosynthesis and Enzymatic GlycodiversificationAngewandte Chemie International Edition, 2008
- Mithramycin Analogues Generated by Combinatorial Biosynthesis Show Improved BioactivityJournal of Natural Products, 2008
- Combinatorial Biosynthesis of Antitumor Deoxysugar Pathways in Streptomyces griseus : Reconstitution of “Unnatural Natural Gene Clusters” for the Biosynthesis of Four 2,6- d -DideoxyhexosesApplied and Environmental Microbiology, 2006
- Inactivation of gilGT, Encoding a C‐Glycosyltransferase, and gilOIII, Encoding a P450 Enzyme, Allows the Details of the Late Biosynthetic Pathway to Gilvocarcin V to be DelineatedChemBioChem, 2006
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990
- Photosensitized DNA breaks and DNA-to-protein crosslinks induced in human cells by antitumor agent gilvocarcin VChemico-Biological Interactions, 1988